Stay updated with breaking news from Carlo Ferri. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The international pharmaceutical BCorp company Ferrer continues to strengthen its focus on pulmonary vascular and interstitial lung diseases by announcing the expansion of its current distribution agreement
The international pharmaceutical BCorp company Ferrer continues to strengthen its focus on pulmonary vascular and interstitial lung diseases by announcing the expansion of its current distribution agreement with United Therapeutics Corporation for Tyvaso a pharmaceutical drugdevice combination product authorized for the treatment of WHO Group 3 Pulmonary Hypertension associated with Interstitial Lung Disease PHILD and for WHO Group 1 Pulmonary Arterial Hypertension PAH.
VRG50635 is one of the first drugs to enter clinical trials that was entirely discovered and developed using an AI-enabled platformSOUTH SAN FRANCISCO, Calif. and BARCELONA, Spain, March 25, 2024 (GLOBE NEWSWIRE) -- Verge Genomics, a leading clinical-stage biotechnology company, and Ferrer, an international B Corp pharmaceutical company with an increasing focus in rare neurological disorders, have announced a strategic collaboration to co-develop VRG50635, Verge’s lead drug candidate, for the tr
Acofarma renueva su colaboración con las farmacias gaditanas en la campaña Stop sol, stop Lupus PMFarma utiliza cookies propias y de terceros para recopilar informacion con la finalidad de mejorar nuestros servicios y mostrarte publicidad relacionada con tus preferencias. Al continuar navegando por el sitio, aceptas el uso de las mismas. Tienes la posibilidad de configurar tu navegador pudiendo impedir que sean instaladas. Configurar | Aceptar Toggle navigation Acofarma renueva su colaboración con las farmacias gaditanas en la campaña Sto...